Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05321407 · ClinicalTrials.gov registry record
COVID-19 Vaccine Responses in PIDD Subjects
A clinical trial of Common Variable Immunodeficiency and Primary Immune Deficiency, sponsored by Duke University.
- Active
- Registry status
- 100
- Enrollment target
- 3
- Study locations
NCT05321407 is a study of Common Variable Immunodeficiency and Primary Immune Deficiency that is active but no longer recruiting, run by Duke University. The registered enrollment target is 100 participants, below the 215-participant average among 7 other Common Variable Immunodeficiency trials with a reported enrollment target (53% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05321407, a study of Common Variable Immunodeficiency and Primary Immune Deficiency, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of our study is to assess the cellular immune responses of participants with antibody deficiency disease before and after immunization with SARS-CoV-2 mRNA vaccines.
Conditions Studied
Study Locations (3)
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
- Duke University - Durham
Florida
- University of South Florida - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2026-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05321407
The ClinicalTrials.gov registry entry for NCT05321407 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 215-participant average among 7 other Common Variable Immunodeficiency trials with a reported enrollment target (53% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Common Variable Immunodeficiency appearing as the primary indexed condition, and to 0 interventions.
NCT05321407 reports 3 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Florida.
Frequently Asked Questions
What is clinical trial NCT05321407 about?
NCT05321407 is a clinical study titled "COVID-19 Vaccine Responses in PIDD Subjects". The goal of our study is to assess the cellular immune responses of participants with antibody deficiency disease before and after immunization with SARS-CoV-2 mRNA vaccines.
What is the current status of trial NCT05321407?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2021-09-30. Estimated completion is 2026-07-31.
What conditions does trial NCT05321407 study?
This clinical trial studies the following conditions: Common Variable Immunodeficiency, Primary Immune Deficiency, CVID, XLA, X-linked Agammaglobulinemia.
Who is sponsoring clinical trial NCT05321407?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05321407 being conducted?
This trial has 3 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Common Variable Immunodeficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
RECRUITING · Phase 2
-
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
RECRUITING · Phase 2
-
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
RECRUITING · Phase 2
-
Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease
RECRUITING · Phase 4
-
Natural History of Bronchiectasis
RECRUITING
-
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.